Membership
Evidence that changes how you walk into your next appointment.
CellIntel briefings pull together the peer-reviewed research, regulatory status, and practitioner questions for the therapies you're weighing — in about 15 seconds, every claim cited. Membership unlocks unlimited briefings and the full research library.
Free Preview
See if CellIntel fits your question.
- Intake summary
- List of modalities considered
- Full safety flags & contraindications (always visible)
- First 3 questions for your practitioner
- One study teaser per modality
- Full evidence per modality
- Saved briefing library
- PDF download
- Re-run on new evidence
Starter
For anyone researching a specific concern.
vs $1,188 if billed monthly — save $289/yr
- 3 full briefings per month
- Full evidence, every claim cited
- Complete practitioner question list
- Standard PDF download
- Saved briefing library (90 days)
- Email delivery
Most popular
Pro
For biohackers & chronic-condition research.
vs $2,388 if billed monthly — save $589/yr
- Unlimited briefings
- Premium PDF with annotated references
- Re-run a briefing when guidance changes
- Priority generation queue
- 2 member profiles
- Permanent saved library
- Priority email support
Family
For caregivers researching for loved ones.
vs $4,188 if billed monthly — save $1,039/yr
- Everything in Pro
- 5 member profiles (spouse, parents, kids)
- Caregiver mode — research as yourself or on behalf of
- Shared family briefing library
- Concierge 30-minute onboarding call
- Priority access to new modalities
Feature comparison
| Feature | Free | Starter | Pro | Family |
|---|---|---|---|---|
| Briefings per month | Preview only | 3 | Unlimited | Unlimited |
| Full cited evidence | — | ✓ | ✓ | ✓ |
| Safety flags & contraindications | ✓ | ✓ | ✓ | ✓ |
| PDF download | — | Standard | Premium | Premium |
| Annotated references bundle | — | — | ✓ | ✓ |
| Re-run on new evidence | — | — | ✓ | ✓ |
| Saved library retention | — | 90 days | Permanent | Permanent |
| Member profiles | 1 | 1 | 2 | 5 |
| Caregiver mode | — | — | — | ✓ |
| Priority generation queue | — | — | ✓ | ✓ |
| Concierge onboarding call | — | — | — | 30 min |
Frequently asked questions
Does CellIntel give me medical advice?
No. CellIntel is educational — a library, not a clinic. Every briefing tells you what the peer-reviewed literature says and what to ask a licensed practitioner. We never recommend a specific treatment, dose, or diagnosis.
What exactly is blurred on the Free Preview?
The evidence summary per modality, the annotated study bundle, and most of the questions for your practitioner are blurred. Safety flags, contraindications, and emergency signals are always fully visible — regardless of plan.
Can I cancel anytime?
Yes. Monthly plans cancel at the end of the current billing cycle. Annual plans can be cancelled any time before renewal. Prorated refunds on annual plans within the first 14 days.
What's the difference between Pro and Family?
Family adds up to 5 member profiles (spouse, aging parents, kids), caregiver mode so you can run briefings on behalf of someone else, a shared family library, and a 30-minute concierge onboarding call. Designed for caregivers researching multiple people's health.
Do I need to be a doctor or scientist to use it?
No. Briefings are written in plain language with references. Every term has a tooltip. If you can read a well-footnoted magazine article, you can use CellIntel.
Is my intake data private?
Yes. Intake data is not shared with advertisers or practitioners unless you opt in to practitioner matching. Your briefing content is never used to train AI models. Full detail in our Privacy Policy.
CellIntel.ai is an educational research tool. It is not medical advice, not a diagnostic tool, and not a substitute for a licensed healthcare practitioner. Regenerative and longevity therapies referenced in CellIntel briefings may not be FDA-approved for the conditions discussed. Membership pricing and features are subject to change with 30 days notice. See our Terms of Service, Privacy Policy, and Medical Disclaimer.